Table 4.
Correlations between different measured parameters
| Parameters | Prolactin | Testosterone | Nesfatin-1 | NADPH | Dopamine |
|---|---|---|---|---|---|
| BMI | |||||
| r=0.362 | r= −0.034 | r=0.004 | r= −0.250 | r=0.395 | |
| p=0.001 | p=0.761 | p=0.970 | p=0.022 | p<0.0001 | |
| WHR | |||||
| r=0.250 | r= −0.118 | r= −0.057 | r= −0.134 | r=0.159 | |
| p=0.022 | p=0.283 | p=0.608 | p=0.226 | p=0.147 | |
| FSI | |||||
| r=0.311 | r=0.082 | r=0.118 | r= −0.224 | r=0.265 | |
| p=0.004 | p=0.458 | p=0.286 | p=0.040 | p=0.015 | |
| HOMA-IR | |||||
| r=0.182 | r=0.130 | r= −0.011 | r= −0.148 | r=0.154 | |
| p=0.097 | p=0.238 | p=0.922 | p=0.179 | p=0.163 | |
| FSH | |||||
| r=0.240 | r= −0.026 | r= −0.058 | r= −0.125 | r=0.272 | |
| p=0.028 | p=0.817 | p=0.600 | p=0.258 | p=0.012 | |
| LH | |||||
| r=0.308 | r=0.212 | r=0.103 | r= −0.092 | r=0.269 | |
| p=0.004 | p=0.052 | p=0.349 | p=0.406 | p=0.013 | |
| Estradiol | |||||
| r=0.545 | r=0.372 | r=0.096 | r= −0.307 | r=0.516 | |
| p<0.0001 | p<0.0001 | p=0.386 | p=0.005 | p<0.0001 | |
| Prolactin | |||||
| - | r=0.204 | r=0.338 | r= −0.281 | r=0.542 | |
| p=0.063 | p=0.002 | p=0.010 | p<0.0001 | ||
| Testosterone | |||||
| - | - | r=0.041 | r= −0.186 | r=0.141 | |
| p=0.708 | p=0.091 | p=0.200 | |||
| Nesfatin-1 | |||||
| - | - | - | r=0.068 | r=0.407 | |
| p=0.538 | p<0.0001 | ||||
| NADPH | |||||
| - | - | - | - | r= −0.213 | |
| p=0.052 |
Data were expressed as correlation coefficient (r) and significance. PCOS: Polycystic Ovary Syndrome, BMI: Body Mass Index, WHR: Waist Hip Ratio, FSI: Fasting Serum Insulin, HOMA-IR: Homeostasis Model Assessment of Insulin Resistance, FSH: Follicle Stimulating Hormone, LH: Luteinizing Hormone, NADPH: Nicotinamide Adenine Dinucleotide Phosphate